Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ELV · Entity 2934 | EVP & Chief Legal Officer | September 02, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,230 |
Ending reported balance
After 2026-09-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-02 · Tax withholding · Disposed 94 · Balance 7,485 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Row 2 · 2026-09-03 · Tax withholding · Disposed 255 · Balance 7,230 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
Filing footnotes · ownership attribution and instrument terms
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 4, 2026 20:06 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 255 | $414.78 | $105,768.90 |
DisclosureSEC source: 0002084548-26-000005 · wk-form4_1788552374.xml · nonDerivative · entry 2 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,230 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:06 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 94 | $405.84 | $38,148.96 |
DisclosureSEC source: 0002084548-26-000005 · wk-form4_1788552374.xml · nonDerivative · entry 1 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,485 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:59 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 417 | $284.03 | $118,440.51 |
DisclosureSEC source: 0002084548-26-000002 · wk-form4_1772661583.xml · nonDerivative · entry 2 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,579 F2 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,754 | $0.00 Strike: $294.07 | $0.00 |
DisclosureSEC source: 0002084548-26-000002 · wk-form4_1772661583.xml · derivative · entry 3 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,754 Underlying: Common Stock · 11,754 shares Expires 2036-03-02 F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 2,976 | $0.00 | $0.00 |
DisclosureSEC source: 0002084548-26-000002 · wk-form4_1772661583.xml · nonDerivative · entry 1 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,996 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:21 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 152 | $321.59 | $48,881.68 |
DisclosureSEC source: 0002084548-25-000004 · wk-form4_1757103700.xml · nonDerivative · entry 1 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,020 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 15:53 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,541 | $0.00 Strike: $322.33 | $0.00 |
DisclosureSEC source: 0002084548-25-000002 · wk-form4_1757001225.xml · derivative · entry 2 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,541 Underlying: Common Stock · 3,541 shares Expires 2035-09-02 F2 · derivative.exercise_date: The option represents a right to purchase a total of 3,541 shares, and is exercisable in three annual installments, with two installments of 1,180 shares each and one installment of 1,181 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 15:53 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 931 | $0.00 | $0.00 |
DisclosureSEC source: 0002084548-25-000002 · wk-form4_1757001225.xml · nonDerivative · entry 1 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,172 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 310 shares each on 9/2/2026 and 9/2/2027, and 311 on 9/2/2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.